Clinical Sales Manager (Detroit) at Karius

Detroit, Michigan, United States

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

Experience in sales, ideally within the life sciences or medical technology industry
Deep knowledge and experience in the greater metropolitan area health systems (Michigan and Indiana)
Ability to engage key stakeholders in the hospital decision-making process
Strong understanding of consultative sales techniques
Ability to present product features and benefits to clinical stakeholders
Ability to serve as a subject matter expert on scientific and technological concepts
Ability to build and manage relationships with hospital and health system accounts

Responsibilities

Grow sales revenue and test volume in territory
Introduce Karius' diagnostic technology to hospitals and health systems
Collaborate with internal teams (Inside Sales, Customer Success, Medical Affairs, and Marketing)
Develop thought leaders and early adopters for Karius' approach to infectious disease diagnosis
Build, manage, and nurture market-based/regional territory
Prioritize and segment hospital & health system accounts
Present product features and benefits to key stakeholders
Manage early evaluations to drive initial adoption of the Karius test
Serve as a subject matter expert on the science and technology of the Karius test

Skills

Karius

Non-invasive diagnostic tests for infections

About Karius

Karius focuses on medical diagnostics for infectious diseases, offering the Karius Test, which detects over 1,000 pathogens from a single blood sample. This non-invasive test is quick and helps clinicians treat hospitalized patients by reducing the need for multiple invasive tests that can delay treatment. The Karius Test utilizes advanced genomics and artificial intelligence to identify microbial cell-free DNA (mcfDNA) in the bloodstream, providing insights into the pathogens responsible for infections. Karius sells these diagnostic tests to healthcare providers, aiming to offer a faster and less invasive alternative to traditional methods, ultimately saving lives and reducing healthcare costs. The company employs proprietary machine learning algorithms to analyze genomic data in real time, continuously updating its reference genome databases to enhance its diagnostic capabilities.

Redwood City, CaliforniaHeadquarters

2014Year Founded

$311.3MTotal Funding

SERIES_CCompany Stage

Biotechnology, HealthcareIndustries

51-200Employees

Benefits

Remote Work Options

Hybrid Work Options

Risks

Competition from AlphaFold 3 could overlap with Karius's genomic insights.

Rapid AI advancements by competitors may outpace Karius's technology.

Reliance on continuous funding rounds indicates potential financial instability.

Differentiation

Karius Test detects over 1,000 pathogens from a single blood sample.

The test uses advanced genomics and AI for rapid, non-invasive diagnostics.

Karius's proprietary algorithms analyze genomic data in real time.

Upsides

Karius secured $100M to expand its test beyond 400 U.S. hospitals.

FDA Breakthrough Device Designation boosts credibility and market potential.

Growing demand for non-invasive diagnostics aligns with Karius's offerings.

Land your dream remote job 3x faster with AI

Try Jobo Free